Ad
related to: triple hit dlbcl prognosis- Pediatric Treatment
Learn More About a Hodgkin Lymphoma
Treatment Option for Your Child.
- Support & Resources
Explore Support & Resource Info
on a Hodgkin's Treatment Option.
- What to Expect
Learn More About What to Expect
From a Hodgkin Lymphoma Treatment.
- Study Results
Visit the Site to Access Clinical
Study Results & Side Effects Info.
- Pediatric Treatment
Search results
Results from the WOW.Com Content Network
Diffuse large B-cell lymphoma (DLBCL) is a cancer of B cells, a type of lymphocyte that is responsible for producing antibodies.It is the most common form of non-Hodgkin lymphoma among adults, [1] with an annual incidence of 7–8 cases per 100,000 people per year in the US and UK.
ABC subtype DLBCL, characterized by gene alterations (at CDKN2A) affecting NF-κB signaling, is associated with worse survival outcomes and increased CNS tropism. [14] Additionally, double-hit or triple-hit lymphomas, defined by chromosomal translocations involving MYC, BCL2, and/or BCL6 oncogenes, confer higher risks of CNS recurrence. [13]
Prognosis and treatment depends on the specific type of lymphoma as well as the stage and grade. Treatment includes radiation and chemotherapy. Early-stage indolent B-cell lymphomas can often be treated with radiation alone, with long-term non-recurrence.
A study of DLBCL cell lines indicated that 14-3-3ζ proteins may play a role in mediating resistance of DLBCL cells to CHOP. 14-3-3 proteins exert anti-apoptotic activity by interfering with the function of BH3-only proteins and has been validated as a potential molecular target for anticancer therapeutic development in other types of cancers.
It has a 5-year overall survival rate of 40–55%, although the PCDLBCL-O variant has a better prognosis than cases in which the legs are involved. [ 5 ] Most lymphomas begin in a lymph node , mucosa-associated lymphoid tissue , the spleen , or another lymphoid tissue within the lymphatic system and then may spread to the skin.
Primary central nervous system lymphoma (PCNSL), also termed primary diffuse large B-cell lymphoma of the central nervous system (DLBCL-CNS), [2] is a primary intracranial tumor appearing mostly in patients with severe immunodeficiency (typically patients with AIDS). It is a subtype and one of the most aggressive of the diffuse large B-cell ...
Aggressive lymphoma, also known as high-grade lymphoma, is a group of fast growing non-Hodgkin lymphoma. [1]There are several subtypes of aggressive lymphoma. These include AIDS-associated lymphoma, angioimmunoblastic lymphoma, Burkitt lymphoma, central nervous system (CNS) lymphoma, diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and peripheral T-cell lymphoma. [1]
PT-DLBCL is by far the most common form of testicular cancer in men >60 years of age. [2] It usually develops in this age group (median age ~65 years old, range 10–96 years) and presents as a painless testicular mass or swelling in one testis or, in ~6% of cases, both testes: [1] PT-DLBCL is the most common testicular cancer to present with disease in both testicles. [8]
Ad
related to: triple hit dlbcl prognosis